SHA:603858 Market Cap

SHA:603858 has a market cap or net worth of 17.50 billion as of March 9, 2026. Its market cap has increased by 8.65% in one year.

Market Cap

17.50B

Enterprise Value

19.26B

Revenue

10.96B

Ranking

n/a

PE Ratio

10,522.96

Stock Price

16.59

Market Cap Chart

Since November 18, 2016, SHA:603858's market cap has decreased from 54.86B to 17.50B, a decrease of -68.11%. That is a compound annual growth rate of -11.56%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	17.63B	6.91%
Dec 31, 2025	16.49B	-2.05%
Dec 31, 2024	16.84B	-10.50%
Dec 29, 2023	18.81B	-19.04%
Dec 30, 2022	23.24B	-0.38%
Dec 31, 2021	23.33B	-8.58%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tonghua Dongbao Pharmaceutical	17.57B
Zhejiang Medicine	17.42B
Fujian Cosunter Pharmaceutical	17.04B
Betta Pharmaceuticals	18.52B
Walvax Biotechnology	18.68B
China Resources Double-Crane Pharmaceutical	18.79B
Shenzhen Kangtai Biological Products	15.73B
Nanjing King-Friend Biochemical Pharmaceutical	15.66B

Market Cap Rankings